Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis.

导出 OA

翻译打印收藏纠错

作者： Karolina,Dahms ^[1] ; Agata,Mikolajewska ^[2] ; Kelly,Ansems ^[3] ; Maria-Inti,Metzendorf ^[4] ; Carina,Benstoem ^[3] ; Miriam,Stegemann ^[5]

作者单位： Department of Intensive Care Medicine and Intermediate Care, Medical Faculty, RWTH Aachen University, Aachen, Germany. kdahms@ukaachen.de. ^[1] Robert Koch Institute, Centre for Biological Threats and Special Pathogens (ZBS), Clinical Management and Infection Control, Berlin, Germany. ^[2] Department of Intensive Care Medicine and Intermediate Care, Medical Faculty, RWTH Aachen University, Aachen, Germany. ^[3] Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. ^[4] Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany. ^[5]

关键词 Anakinra COVID-19 Hospitalization Interleukin 1 receptor antagonist protein Meta-analysis SARS-CoV-2 Systematic review

主题词成年人(Adult);人类(Humans);男(雄)性(Male);中年人(Middle Aged);女(雌)性(Female);白细胞介素1受体拮抗蛋白质(Interleukin 1 Receptor Antagonist Protein)

DOI 10.1186/s40001-023-01072-z

PMID 36841793

发布时间 2023-02-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交